Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Regulatory Analysis
4.3.1. Overview
4.3.2. U.S.
4.3.3. Canada
4.3.4. Europe
4.3.5. Asia-Pacific
4.3.5.1. China
4.3.5.2. Japan
4.3.5.3. India
4.3.6. Latin America
4.3.7. Middle East
4.4. Pricing Analysis
4.5. Industry & Technology Trends
4.5.1. Shift from Traditional Newborn Screening to Advanced Technologies
4.5.2. Laws and Initiatives Supporting Newborn Screening Across Countries
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition

5. Newborn Screening Market Assessment?by Product
5.1. Overview
5.2. Instruments
5.3. Consumables

6. Newborn Screening Market Assessment?by Technology
6.1. Overview
6.2. Tandem Mass Spectrometry
6.3. Immune Assays & Enzymatic Assays
6.4. Molecular Assays
6.5. Pulse Oximetry
6.6. Hearing Screening Technologies
6.7. Other Technologies

7. Newborn Screening Market Assessment?by Application
7.1. Overview
7.2. Inherited Disorders
7.2.1. Metabolic Disorders
7.2.2. Hemoglobin Disorders
7.2.3. Endocrine Disorders
7.2.4. Other Inherited Disorders
7.3. Infectious Diseases
7.4. Congenital Heart Disease
7.5. Hearing Disorders
7.6. Other Applications

8. Newborn Screening Market Assessment?by End User
8.1. Overview
8.2. Hospitals
8.3. Reference Laboratories

9. Newborn Screening Market Assessment?by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa

10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. PerkinElmer, Inc.
11.2. Thermo Fisher Scientific, Inc.
11.3. Bio-Rad Laboratories, Inc.
11.4. Medtronic plc
11.5. F. Hoffmann-La Roche AG
11.6. ARCHIMED Group
11.7. Trivitron Healthcare Pvt Ltd.
11.8. Demant A/S
11.9. Baebies, Inc.
11.10. ZenTech s.a.
11.11. Other Companies
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix
12.1. Available Customization
12.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Newborn Screening Market, By Product, 2023 Vs. 2030 (USD Million)
Figure 8 Global Newborn Screening Market, By Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Global Newborn Screening Market, By Application, 2023 Vs. 2030 (USD Million)
Figure 10 Global Newborn Screening Market, By End User, 2023 Vs. 2030 (USD Million)
Figure 11 Newborn Screening Market, By Geography
Figure 12 Global Newborn Screening Market: Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2023–2030)
Figure 13 Benefits of Newborn Screening
Figure 14 USFDA Regulatory Pathways for Medical Devices
Figure 15 EU Regulatory Pathway - IVDR 2017/746
Figure 16 China: Medical Device Classification and Premarket Requirements for IVD Devices
Figure 17 Porter’s Five Forces Analysis
Figure 18 Global Newborn Screening Market, By Product, 2023 Vs. 2030 (USD Million)
Figure 19 Global Newborn Screening Market, By Technology, 2023 Vs 2030 (USD Million)
Figure 20 Protocol for Newborn Screening
Figure 21 Global Newborn Screening Market, By Application, 2023 Vs. 2030 (USD Million)
Figure 22 Two-Stage Screening Protocol for Hearing Disorders
Figure 23 Global Newborn Screening Market, By End User, 2023 Vs. 2030 (USD Million)
Figure 24 Global Newborn Screening Market, By Geography, 2023–2030 (USD Million)
Figure 25 North America: Newborn Screening Market Snapshot
Figure 26 Europe: Newborn Screening Market Snapshot
Figure 27 Asia-Pacific: Newborn Screening Market Snapshot
Figure 28 Latin America: Newborn Screening Market Snapshot
Figure 29 Key Growth Strategies Adopted By Leading Players 2020-2023
Figure 30 Newborn Screening Market: Competitive Benchmarking By Product Type
Figure 31 Newborn Screening Market: Competitive Benchmarking, By Region
Figure 32 Competitive Dashboard: Newborn Screening Market
Figure 33 PerkinElmer, Inc.: Financial Overview (2022)
Figure 34 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 35 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 36 Medtronic Plc: Financial Overview (2022)
Figure 37 F. Hoffmann-La Roche AG: Financial Overview (2022)
Figure 38 Demant A/S: Financial Overview (2022)